News - Page 8 of 13 - Xtant Medical

Xtant Medical Announces Second Quarter 2019 Financial Results

August 8, 2019

BELGRADE, Mont. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2019

Xtant Medical to Issue Second Quarter 2019 Financial Results on August 8, 2019

August 1, 2019

Xtant Medical Announces NYSE American Acceptance of Plan to Regain Compliance with Continued Listing Standards

May 28, 2019

BELGRADE, Mont. , May 28, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that NYSE Regulation has accepted the Company’s plan to regain compliance

Xtant Medical Announces First Quarter 2019 Financial Results

May 15, 2019

BELGRADE, Mont. , May 15, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2019 .

Xtant Medical to Issue First Quarter 2019 Financial Results on May 15, 2019

May 8, 2019

BELGRADE, Mont. , May 08, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended

Xtant Medical Receives Noncompliance Notice from NYSE American

April 5, 2019

BELGRADE, Mont. , April 05, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced receipt of notification from the NYSE American that the Company is not in

Xtant Medical Announces Fourth Quarter and 2018 Financial Results

April 1, 2019

BELGRADE, Mont. , April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended

Xtant Medical Announces Amendments and Extension of Credit Facility

April 1, 2019

BELGRADE, Mont. , April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has executed the Second Amended and Restated Credit Agreement

Xtant Medical to Issue Fourth Quarter and Full Year 2018 Financial Results on April 1, 2019

March 28, 2019

BELGRADE, Mont. , March 28, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and

Xtant Medical Announces Appointment of New Senior Sales Leaders

February 12, 2019

BELGRADE, MT , Feb. 12, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the recent additions of five senior sales executives: Dana Lyons , Vice

Xtant Medical Announces Appointment of Chief Operations Officer

January 11, 2019

BELGRADE, MT , Jan. 11, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Ronald Berlin as Vice President & Chief Operations

Xtant Medical Announces Third Quarter 2018 Financial Results

November 14, 2018

BELGRADE, MT , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the third quarter ended September 30, 2018 .